Literature DB >> 24340316

Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists.

Stephen Ip, AbdulRazaq A H Sokoro, Al Buchel, Debrah Wirtzfeld, Gerald Konrad, Tunji Fatoye, Harminder Singh.   

Abstract

BACKGROUND: Although the fecal occult blood test (FOBT) was developed for colorectal cancer screening in the outpatient setting, it continues to be used among hospitalized patients. No previous study has evaluated the knowledge, beliefs and attitudes of practicing physicians on the use of FOBT among hospitalized patients and compared practices among physicians with different medical specialty training.
OBJECTIVE: To survey physicians in the Winnipeg Regional Health Authority (WRHA) and Canadian gastroenterologists (GIs) on the use of FOBT in hospitals.
METHODS: A survey was distributed by e-mail to internists (n=198), emergency medicine (EM) physicians (n=118), general surgeons (n=47) and family medicine (FM) physicians with admitting privileges (n=29) in the WRHA. Canadian GIs were surveyed through the membership database of the Canadian Association of Gastroenterology (CAG) (n=449). The survey included items regarding demographics of the respondents and their current use of FOBT in hospitals.
RESULTS: Response rates ranged from 18% among CAG members to 69% among FM physicians in the WRHA. General internal medicine, general surgeon and GI respondents were less likely to order a FOBT and less likely to believe that an FOBT was useful in assessing emergency room or hospitalized patients when compared with FM and EM respondents (P<0.001). The most common indications for ordering a FOBT were black stools and anemia with and without iron deficiency. Two-thirds of EM physicians preferred point-of-care testing rather than laboratory reporting of FOBT.
CONCLUSIONS: The present survey suggests that FOBTs are commonly used in hospitals by EM and FM physicians for indications such as anemia and black stools.

Entities:  

Mesh:

Year:  2013        PMID: 24340316      PMCID: PMC3915014          DOI: 10.1155/2013/816305

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  13 in total

1.  Point of care testing.

Authors:  James H Nichols
Journal:  Clin Lab Med       Date:  2007-12       Impact factor: 1.935

2.  Faecal occult blood tests--eliminate, enhance or update?

Authors:  Callum G Fraser
Journal:  Ann Clin Biochem       Date:  2008-03       Impact factor: 2.057

Review 3.  Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Jennifer S Lin; Elizabeth Liles; Tracy L Beil; Rongwei Fu
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

Review 4.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

5.  Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.

Authors:  M A Sinatra; D J St John; G P Young
Journal:  Clin Chem       Date:  1999-01       Impact factor: 8.327

6.  Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.

Authors:  V K Sharma; F A Corder; J Fancher; C W Howden
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

7.  An audit of the utility of in-patient fecal occult blood testing.

Authors:  V K Sharma; S Komanduri; S Nayyar; A Headly; P Modlinger; D C Metz; V J Verghese; A Wanahita; M F Go; C W Howden
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

8.  Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey.

Authors:  V K Sharma; R Vasudeva; C W Howden
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

9.  Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations.

Authors:  Linda Rabeneck; Caroline Zwaal; Joel Hartley Goodman; Verna Mai; Mo Zamkanei
Journal:  Clin Biochem       Date:  2008-08-29       Impact factor: 3.281

Review 10.  A new view of occult and obscure gastrointestinal bleeding.

Authors:  Sara H Mitchell; David C Schaefer; Srinivasan Dubagunta
Journal:  Am Fam Physician       Date:  2004-02-15       Impact factor: 3.292

View more
  2 in total

1.  Putting an end to the misuse of the fecal occult blood test in diagnostic medicine.

Authors:  Catherine Dubé
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

2.  Use of fecal occult blood testing in hospitalized patients: results of an audit.

Authors:  Stephen Ip; AbdulRazaq A H Sokoro; Lisa Kaita; Claudia Ruiz; Elaine McIntyre; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2014-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.